Abstract:In this editorial, we comment on the article published by Agatsuma et al in a recent issue of the World J Gastroenterol (2024; 30: 1368-1376). We firmly concur with Agatsuma et al regarding the vital significance of colorectal cancer (CRC) screening as a public health strategy to diminish disease burden. Individuals exposed to risk factors for CRC, those with comorbid conditions, and those with limited health literacy should undergo screening. However, we believe that more regular screenings should be accompanied by a greater focus on primary prevention (PP) of CRC. CRC remains a significant global health challenge, and its incidence is strongly linked to age, lifestyle, and socioeconomic factors. It is particularly noteworthy that the majority of CRC patients are diagnosed outside of established screening pathways and frequently at an advanced stage of the disease, and the majority of patients possess inadequate or even nonexistent knowledge regarding CRC, which significantly impacts the prognosis and imposes a substantial economic burden. This study revealed that CRC identified during hospital visits for comorbid conditions was typically diagnosed at an earlier stage than detected via symptomatic pathways. Remarkably, early incidental detection of CRC aligns closely with the timing of discovery through routine cancer screenings. This suggests that by adopting more inclusive screening protocols that combine opportunistic testing with traditional screening methods, health care systems can create a more comprehensive safety net for individuals at risk of CRC. However, before maximizing the health benefits of screening programs, it is essential to make additional efforts prior to screening, such as raising awareness via public education, risk assessment, and personalized recommendations, enhancing the knowledge and skills of health care professionals, optimizing the accessibility and convenience of screening processes, ensuring the quality and safety of screening services, strengthening follow-up and support systems, and providing policy support and financial investment. The establishment of a comprehensive screening system often requires substantial investment in human, material, and financial resources, which can be challenging to achieve in regions with limited health care resources. Strengthening PP strategies can reduce the disease burden by targeting the cause, representing a more cost-effective and impactful approach. Establishing a comprehensive cancer PP service platform that integrates authoritative public education on malignant tumor PP, individualized malignant tumor risk assessment, and self-health management assistance accessible to the entire population will significantly enhance the overall effectiveness of CRC PP strategies.

Colorectal cancer screening and prevention

Updated American Cancer Society lung cancer screening guidelines

Improving follow‐up of abnormal cancer screening results

Colorectal Cancer Screening in a Changing World

Colorectal cancer screening: Modalities and adherence

Healthy Food Choices, Physical Activity, and Screening Reduce the Risk of Colorectal Cancer

Colon cancer screening: What to choose?

Colon Cancer: A Clinician’s Perspective in 2019

Advances in Epigenetic Biomarker Research in Colorectal Cancer.

NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024

Improving colorectal cancer screening programs

Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection

Improving Noninvasive Colorectal Cancer Screening

Colon Cancer Screening Methods: 2023 Update

Improving colorectal cancer screening in primary care practice: innovative strategies and future directions

Optimal Strategies for Colorectal Cancer Screening

Who should be screened for colorectal cancer and how can it be prevented more effectively?

Optimization of colorectal cancer screening strategies: New insights

Precision medicine and immunotherapy advances transforming colorectal cancer treatment

The Roadmap of Colorectal Cancer Screening

Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy